CSIMarket
 
Psychemedics Corporation  (PMD)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Psychemedics's Customers Performance

PMD



 
PMD's Source of Revenues During the corresponding time, Psychemedics Corporation saw a revenue deteriorated by -18.8 % year on year, sequentially revenue fell by -12.92 %. While revenue at the Psychemedics Corporation's corporate clients

List of PMD Customers




for the same period Psychemedics Corporation revnue deteriorated by -18.8 % year on year, sequentially revenue fell by -12.92 %.

List of PMD Customers

Psychemedics's Business Units






Psychemedics's Comment on Sales, Marketing and Customers



Psychemedics utilizes a patented hair testing method to detect drug use, which demonstrates a higher detection rate compared to urinalysis testing. This method is applied in market segments such as pre-employment and random drug testing. In 1998, the National Institute of Justice conducted a study using Psychemedics' hair testing assay at a Pennsylvania prison to monitor drug use levels. Additionally, the Federal Bureau of Investigation performed a study analyzing Psychemedics' decontamination wash protocol, confirming its effectiveness in preventing false positives from environmental contamination. Psychemedics' hair testing provides long-term historical drug use information, typically covering approximately three months, and is used for monitoring populations and deterring drug use.


  News about Psychemedics Corporation Contracts

Psychemedics Corporation Introduces Ketamine Hair Testing Service Amid Market Challenges,

Psychemedics Corporation Unveils New Ketamine Hair Testing Service Amidst Market Performance Challenges Psychemedics Corporation, a pioneering figure in drug testing technology, has taken a significant leap forward with the announcement of their latest innovation: a state-of-the-art ketamine hair testing service. This cutting-edge solution underscores Psychemedics unwavering commitment to advancing the field of drug detection and providing reliable, long-term substance abuse monitoring.As ketamine use has grown in both medical and illicit settings, the demand for efficient and comprehensive detection methods has surged. Known for its potential therapeutic applications as well as its abuse potential, ketamin...

Psychemedics Corporation: Pioneering Drug Abuse Testing from Its New Home in Dallas, Texas

In a strategic move, Psychemedics Corporation, a frontrunner in the field of hair testing for drugs of abuse, has announced the relocation of its corporate headquarters to Dallas, Texas. This significant decision is set to solidify Psychemedics Corporation s position as a global leader in the industry, benefiting both the company and its clients. In this article, we will delve into the reasons behind this relocation and the potential impact it holds.Unveiling the Motivation behind the Move:Psychemedics Corporation s decision to shift its headquarters signifies a carefully analyzed strategy aimed at enhancing its market presence, operational efficiency, and growth prospects. By relocating to Dallas, the compa...




Psychemedics’s Comment on Sales, Marketing and Customers


Psychemedics utilizes a patented hair testing method to detect drug use, which demonstrates a higher detection rate compared to urinalysis testing. This method is applied in market segments such as pre-employment and random drug testing. In 1998, the National Institute of Justice conducted a study using Psychemedics' hair testing assay at a Pennsylvania prison to monitor drug use levels. Additionally, the Federal Bureau of Investigation performed a study analyzing Psychemedics' decontamination wash protocol, confirming its effectiveness in preventing false positives from environmental contamination. Psychemedics' hair testing provides long-term historical drug use information, typically covering approximately three months, and is used for monitoring populations and deterring drug use.








PMD's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Psychemedics Corporation 15.66 19.10 -1.86 101
SUBTOTAL 0.00 0.00 0.00 -

Sources: Psychemedics Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Psychemedics Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Psychemedics Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.